list of fda approved glp-1 receptor agonists Overview Available in the United States for GLP-1 Medications for Weight Loss:

Description

The combined effect is sustainable and safe weight loss for people who take a GLP-1 agonist medication under medical supervision, according to a clinical review of GLP-1 receptor agonists published in Drugs in Context

Notes: As of Oct

Medical aid coverage Spotlight requested details on the coverage provided to medical scheme members for GLP-1 agonists for the treatment of type 2 diabetes and obesity from Discovery and Momentum

Table of Contents: What not to eat on Semaglutide GLP-1

As broad guidelines, monthly out-of-pocket costs for brand-name GLP-1 medications fall roughly in the following ranges: Ozempic : typically $250 to $400, depending on dose Rybelsus : typically $250 to $300 Wegovy : typically $400 to $600 Mounjaro and Zepbound : Following Eli Lillys December 2025 price reduction, between around $300 to $540 depending on dose Generic Semaglutide (Ozempic): Could be more than 50% cheaper than branded Ozempic, depending on how many manufacturers enter the market These are list-price estimates only